Larvol Delta - Almirall-delivers-solid-H1-2026-results-growing-Net-Sales-by-75-and-EBITDA-by-237-driven-by-its-strong-European-Dermatology-business--reiterating-guidance-aligned-with-longterm-growth-trajectory

Ebglyss (lebrikizumab-lbkz) - Eli Lilly

Wynzora (calcipotriene/betamethasone dipropionate) - MC2 Therap, Almirall

Ilumya (tildrakizumab-asmn) - Sun Pharma, Almirall

Klisyri (tirbanibulin ointment) - Almirall

Jul 24, 2026